Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1960;21:1126-1133

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LONG, R. T. L.
Right arrow Articles by MORROW, A. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LONG, R. T. L.
Right arrow Articles by MORROW, A. G.

(Circulation. 1960;21:1126.)
© 1960 American Heart Association, Inc.


Intracardiac Injection of Radioactive Krypton

Clinical Applications of New Methods for Characterization of Circulatory Shunts

ROBERT T. L. LONG M.D.1; EUGENE BRAUNWALD M.D.1; ANDREW G. MORROW M.D.1

1 From the Clinic of Surgery, National Heart Institute, Bethesda, Md.

Following injection of krypton85 in solution into the right side of the heart, approximately 95 per cent is cleared during 1 passage through the pulmonary circulation. Arterial blood activity is low when radioactive Kr85 is injected in the absence of, or distal to, the origin of a right-to-left shunt. However, when injected proximal to the origin of such a shunt, a fraction of the Kr85 bypasses the pulmonary capillary bed and appears in arterial blood. Thirty to 50 µc. Kr85 were injected into the right heart, and arterial blood was sampled during the next 15 seconds. In 19 patients without right-to-left shunts, the activity per milliliter of arterial blood was always less than 9.0 x 10–5 and averaged 2.5 ± 2.6 x 10–5 of the total radioactivity injected. In 9 patients with proved right-to-left shunts, the radioactivity per milliliter of arterial blood always exceeded 8.2 x 10–5 and averaged 30.1 ± 12.2 x 10–5 of the total activity injected. By appropriate rearrangement of the Stewart-Hamilton formula the data permit calculation of the magnitude of the right-to-left shunt.

Following injection into the left heart, proximal to the origin of a left-to-right shunt, Kr85 promptly arrives in the pulmonary vascular bed and immediately appears in the expired gas, where it may be readily detected. In 22 such patients Kr85 appeared in the expired gas in an average of 4.0 ± 1.6 seconds. However, after injection distal to the origin of a left-to-right shunt in 18 patients, the appearance of Kr85 in the expired gas was delayed to a mean of 15.0 ± 5.0 seconds.

The technics described are convenient, simple to apply during cardiac catheterization, and sufficiently sensitive to detect and localize even small cardiac shunts.